Literature DB >> 1949386

Development of bacillus Calmette-Guérin-induced antitumor activity in peripheral blood mononuclear cells.

S Koga1, K Taniguchi, M Nishikido, S Kubota, S Yamashita, H Kanetake, Y Saito.   

Abstract

Peripheral blood mononuclear cells (PBMNCs) after bladder instillation of bacillus Calmette-Guérin (BCG) to patients with superficial bladder carcinoma showed lytic activity against natural killer (NK)-sensitive and NK-resistant target tumor cells. PBMNCs in normal volunteers were isolated and cultured with BCG (5 micrograms/ml) in vitro. Maximum cytotoxicity was obtained within 24 h. Cytosine arabinoside as a DNA synthesis inhibitor did not inhibit this killer cell activation. Monoclonal antibody treatment revealed that both precursor and effector cells were NK cell type. However, effector cells had a wider spectrum of target cells than usual NK cells. The recognition specificity from cold target competition experiments was selective.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1949386     DOI: 10.1159/000282259

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  2 in total

1.  Bacillus Calmette Guérin in bladder cancer: is more immune stimulation better?

Authors:  Mar Valés-Gómez
Journal:  Transl Androl Urol       Date:  2019-12

2.  Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing.

Authors:  K Pryor; J Goddard; D Goldstein; P Stricker; P Russell; D Golovsky; R Penny
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.